Top endocrinology stories: Diabetes association announces new resource, availability of diabetes medicines poor

The top story in endocrinology this week was the American Association of Diabetes Educators, or AADE, announcing the establishment of a new technology-based resource called Diabetes Advanced Network Access.

Other top stories included studies that found that the availability and affordability of essential diabetes medicines is poor worldwide, exercise may prolong early partial remission of type 1 diabetes, high aldosterone levels may increase the risk for type 2 diabetes and women with polycystic ovary syndrome have no increased risk for CVD.

AADE announces technology hub DANA, a new resource for health care professionals

The Helmsley Charitable Trust is providing the American Association of Diabetes Educators with a $2.6 million grant to be used for its new technology-based resource Diabetes Advanced Network Access, or DANA, according to a press release from AADE. Read more.

Overall availability, affordability of essential diabetes medicines poor worldwide

Insulin was available to those with diabetes who need it in only half of surveyed pharmacies worldwide, whereas the availability of metformin and sulfonylureas varied across low-income vs. high-income countries, according to findings published in The Lancet Diabetes & Endocrinology. Read more.

Exercise may prolong early partial remission of type 1 diabetes

Among men with new-onset type 1 diabetes, exercise can play a role in extending the “honeymoon” period of partial remission after diagnosis, according to findings published in Diabetic Medicine. Read more.

High aldosterone level may raise type 2 diabetes risk

Adults with higher aldosterone levels are more likely to develop type 2 diabetes over 10 years vs. those with lower levels, with the risk further increasing for Asian, black and Hispanic adults, according to findings published in the Journal of the American Heart Association. Read more.

No increased CVD risk observed in PCOS

Women with polycystic ovary syndrome are at higher risk for obesity and elevated cholesterol vs. healthy women, but researchers observed no increased prevalence of cardiovascular disease in this population, according to findings published in Diabetes/Metabolism Research and Reviews. Read more.